NCT03677817View on ClinicalTrials.gov

Perioperative Lidocaine Administration in Thoracoscopic Surgery for Improved Postoperative Pain Control

PHASE3CompletedINTERVENTIONAL
Enrollment

113

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

August 28, 2022

Study Completion Date

August 28, 2022

Conditions
Postoperative Pain
Interventions
DRUG

Lidocaine

regimen of lidocaine administration of 1,5 mg/kg, IV bolus, followed by continuous infusion at 3,0 mg/kg/h

DRUG

NaCl 0,9%

IV bolus of NaCl 0,9%, followed by continuous infusion of NaCl 0,9%

Trial Locations (1)

4031

Division of Thoracic Surgery,University Hospital of Basel, Basel

All Listed Sponsors
lead

University Hospital, Basel, Switzerland

OTHER

NCT03677817 - Perioperative Lidocaine Administration in Thoracoscopic Surgery for Improved Postoperative Pain Control | Biotech Hunter | Biotech Hunter